Advertisement
| aha guidelines htn: Home Blood Pressure Monitoring George S. Stergiou, Gianfranco Parati, Giuseppe Mancia, 2019-10-31 Hypertension remains a leading cause of disability and death worldwide. Self-monitoring of blood pressure by patients at home is currently recommended as a valuable tool for the diagnosis and management of hypertension. Unfortunately, in clinical practice, home blood pressure monitoring is often inadequately implemented, mostly due to the use of inaccurate devices and inappropriate methodologies. Thus, the potential of the method to improve the management of hypertension and cardiovascular disease prevention has not yet been exhausted. This volume presents the available evidence on home blood pressure monitoring, discusses its strengths and limitations, and presents strategies for its optimal implementation in clinical practice. Written by distinguished international experts, it offers a complete source of information and guide for practitioners and researchers dealing with the management of hypertension. |
| aha guidelines htn: Diabetes and Hypertension Samy I. McFarlane, George L. Bakris, 2012-10-19 Diabetes and hypertension have evolved as two of the modern day epidemics affecting millions of people around the world. These two common co-morbidities lead to substantial increase in cardiovascular disease, the major cause of morbidity and mortality of adults around the world. In Diabetes and Hypertension: Evaluation and Management, a panel of renowned experts address a range of critical topics -- from basic concepts in evaluation and management of diabetes and hypertension, such as dietary interventions, to evaluation and management of secondary hypertension in clinical practice. Other chapters focus on high cardiovascular risk populations such as those with coronary heart disease, chronic kidney disease and minority patients. In addition, evolving concepts and new developments in the field are presented in other chapters, such as prevention of type 2 diabetes and the epidemic of sleep apnea and its implication for diabetes and hypertension evaluation and management. An important title covering two of the most troubling disorders of our time, Diabetes and Hypertension: Evaluation and Management will provide the busy practitioner with cutting edge knowledge in the field as well as practical information that can translate into better care provided to the high-risk population of diabetics and hypertensive patients. |
| aha guidelines htn: Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure, |
| aha guidelines htn: From Hypertension to Heart Failure Michael Böhm, John H. Laragh, Manfred Zehender, 2012-12-06 Arterial hypertension, coronary heart disease and heart fail ure are the commonest cardiovascular conditions to present in clinical practice. Over the past few years it has become in creasingly clear that they are closely and causally interrelated and that their relationship can have a significant bearing on prognosis. Epidemiological studies have shown that arterial hypertension is one of the most important risk factors for de veloping heart failure. Only one in four patients with hyper tension is adequately managed, and in 50% of cases, the hypertension has not been recognised or treated. Patients with pre-existing hypertension who go on to suffer an acute myocardial infarction have usually not previously had typi cal angina symptoms, the infarct territory is larger, life threatening arrhythmias are commoner and hence in-hospi tal mortality and long-term prognosis are markedly worse. The presence of raised blood pressure in the post-infarct phase doubles the risk of manifest heart failure. The close relationship between hypertension, coronary heart disease and heart failure makes the choice of therapeu tic strategy particularly important. Agents and classes of agents that have prognostic value in all three conditions should be considered first, as synergy might result in addi tional benefits. In such patients, this sort of therapeutic deci sion-making might have further advantages. The use of these agents may prevent complications which are not yet clinically obvious (such as heart failure). |
| aha guidelines htn: Your Guide to Lowering Your Blood Pressure with Dash U. S. Department Human Services, National Health, Department Of Health And Human Services, Lung, and Blood, National Heart Institute, National Heart Lung Institute, And, 2012-07-09 This book by the National Institutes of Health (Publication 06-4082) and the National Heart, Lung, and Blood Institute provides information and effective ways to work with your diet because what you choose to eat affects your chances of developing high blood pressure, or hypertension (the medical term). Recent studies show that blood pressure can be lowered by following the Dietary Approaches to Stop Hypertension (DASH) eating plan-and by eating less salt, also called sodium. While each step alone lowers blood pressure, the combination of the eating plan and a reduced sodium intake gives the biggest benefit and may help prevent the development of high blood pressure. This book, based on the DASH research findings, tells how to follow the DASH eating plan and reduce the amount of sodium you consume. It offers tips on how to start and stay on the eating plan, as well as a week of menus and some recipes. The menus and recipes are given for two levels of daily sodium consumption-2,300 and 1,500 milligrams per day. Twenty-three hundred milligrams is the highest level considered acceptable by the National High Blood Pressure Education Program. It is also the highest amount recommended for healthy Americans by the 2005 U.S. Dietary Guidelines for Americans. The 1,500 milligram level can lower blood pressure further and more recently is the amount recommended by the Institute of Medicine as an adequate intake level and one that most people should try to achieve. The lower your salt intake is, the lower your blood pressure. Studies have found that the DASH menus containing 2,300 milligrams of sodium can lower blood pressure and that an even lower level of sodium, 1,500 milligrams, can further reduce blood pressure. All the menus are lower in sodium than what adults in the United States currently eat-about 4,200 milligrams per day in men and 3,300 milligrams per day in women. Those with high blood pressure and prehypertension may benefit especially from following the DASH eating plan and reducing their sodium intake. |
| aha guidelines htn: National High Blood Pressure Education Program National High Blood Pressure Education Program. Working Group on Primary Prevention of Hypertension, 1993 This report reviews the rationale for primary prevention of hypertension, strategies for prevention of hypertension, and efficacy of interventions to prevent hypertension. Includes policy recommendations. |
| aha guidelines htn: Build and Blood Pressure Study Society of Actuaries, 1959 |
| aha guidelines htn: The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents Bonita Falkner, 2006-02-01 The fourth report from the Nat. High Blood Pressure Educ. Program (NHBPEP) Working Group on Children & Adolescents. This report updates clinicians on the latest recommendations concerning the diagnosis, evaluation, & treatment of hypertension in children; recommendations are based on English-language, peer-reviewed, scientific evidence (from 1997 to 2004) & the consensus expert opinion of the NHBPEP Working Group. This report includes new data from the 1999-2000 Nat. Health & Nutrition Exam. Survey, as well as revised blood pressure tables that include the 50th, 90th, 95th, & 99th percentiles by sex, age, & height. Charts & tables. |
| aha guidelines htn: Finding What Works in Health Care Institute of Medicine, Board on Health Care Services, Committee on Standards for Systematic Reviews of Comparative Effectiveness Research, 2011-07-20 Healthcare decision makers in search of reliable information that compares health interventions increasingly turn to systematic reviews for the best summary of the evidence. Systematic reviews identify, select, assess, and synthesize the findings of similar but separate studies, and can help clarify what is known and not known about the potential benefits and harms of drugs, devices, and other healthcare services. Systematic reviews can be helpful for clinicians who want to integrate research findings into their daily practices, for patients to make well-informed choices about their own care, for professional medical societies and other organizations that develop clinical practice guidelines. Too often systematic reviews are of uncertain or poor quality. There are no universally accepted standards for developing systematic reviews leading to variability in how conflicts of interest and biases are handled, how evidence is appraised, and the overall scientific rigor of the process. In Finding What Works in Health Care the Institute of Medicine (IOM) recommends 21 standards for developing high-quality systematic reviews of comparative effectiveness research. The standards address the entire systematic review process from the initial steps of formulating the topic and building the review team to producing a detailed final report that synthesizes what the evidence shows and where knowledge gaps remain. Finding What Works in Health Care also proposes a framework for improving the quality of the science underpinning systematic reviews. This book will serve as a vital resource for both sponsors and producers of systematic reviews of comparative effectiveness research. |
| aha guidelines htn: Hypertension: A Companion to Braunwald's Heart Disease E-Book George L. Bakris, Matthew Sorrentino, 2017-01-03 The third edition of Hypertension: A Companion to Braunwald's Heart Disease, by Drs. George L. Bakris and Matthew Sorrentino, focuses on every aspect of managing and treating patients who suffer from hypertensive disorders. Designed for cardiologists, endocrinologists and nephrologists alike, this expansive, in-depth review boasts expert guidance from contributors worldwide, keeping you abreast of the latest developments from basic science to clinical trials and guidelines. - Features expert guidance from worldwide contributors in cardiology, endocrinology, neurology and nephrology. - Covers behavior management as an integral part of treatment plans for hypertensives and pre-hypertensives. - Covers new developments in epidemiology, pathophysiology, immunology, clinical findings, laboratory testing, invasive and non-invasive testing, risk stratification, clinical decision-making, prognosis, and management. - Includes chapters on hot topics such as hypertension as an immune disease; sleep disorders including sleep apnea, a major cause of hypertension; a novel chapter on environmental pollution and its contribution to endothelial dysfunction, and more! - Equips you with the most recent guidelines from the major societies. - Updates sourced from the main Braunwald's Heart Disease text. - Highlights new combination drug therapies and the management of chronic complications of hypertension. |
| aha guidelines htn: Sodium Intake in Populations Institute of Medicine, Board on Population Health and Public Health Practice, Food and Nutrition Board, Committee on the Consequences of Sodium Reduction in Populations, 2013-08-27 Despite efforts over the past several decades to reduce sodium intake in the United States, adults still consume an average of 3,400 mg of sodium every day. A number of scientific bodies and professional health organizations, including the American Heart Association, the American Medical Association, and the American Public Health Association, support reducing dietary sodium intake. These organizations support a common goal to reduce daily sodium intake to less than 2,300 milligrams and further reduce intake to 1,500 mg among persons who are 51 years of age and older and those of any age who are African-American or have hypertension, diabetes, or chronic kidney disease. A substantial body of evidence supports these efforts to reduce sodium intake. This evidence links excessive dietary sodium to high blood pressure, a surrogate marker for cardiovascular disease (CVD), stroke, and cardiac-related mortality. However, concerns have been raised that a low sodium intake may adversely affect certain risk factors, including blood lipids and insulin resistance, and thus potentially increase risk of heart disease and stroke. In fact, several recent reports have challenged sodium reduction in the population as a strategy to reduce this risk. Sodium Intake in Populations recognizes the limitations of the available evidence, and explains that there is no consistent evidence to support an association between sodium intake and either a beneficial or adverse effect on most direct health outcomes other than some CVD outcomes (including stroke and CVD mortality) and all-cause mortality. Some evidence suggested that decreasing sodium intake could possibly reduce the risk of gastric cancer. However, the evidence was too limited to conclude the converse-that higher sodium intake could possibly increase the risk of gastric cancer. Interpreting these findings was particularly challenging because most studies were conducted outside the United States in populations consuming much higher levels of sodium than those consumed in this country. Sodium Intake in Populations is a summary of the findings and conclusions on evidence for associations between sodium intake and risk of CVD-related events and mortality. |
| aha guidelines htn: Cardiovascular Diseases and Depression Bernhard T. Baune, Phillip J. Tully, 2016-08-01 The world is witnessing a burgeoning global epidemic of chronic cerebro- and cardiovascular disease and depression disorders. The reader will find this comprehensive book to be a long-needed, up-to-date knowledge base on these increasingly recognized comorbid conditions that have long-term consequences for individual function and well-being and society in general. This comprehensive book outlines the complex and bidirectional relationship between various types of depression and cerebro- and cardiovascular diseases. It is written by a range of experts in the field, including psychiatrists, cardiologists, neuroscientists, psychologists, and epidemiologists, with the aim of presenting and discussing the most recent evidence on the pathophysiology, neurobiology, and clinical presentation of these common and disabling comorbid conditions and the available pharmacological, psychological, and behavioral interventions. By elucidating the underlying clinical and neurobiological mechanisms in the brain and the rich interplay between the body and the brain biology, the book brings together the latest knowledge of this overlapping area in Psychiatry and Cardiology. The clear descriptions of evidence-based approaches to clinical treatment ensure that it will serve as both an up-to-date overview and a future guide for practicing clinicians and graduate students. |
| aha guidelines htn: Clinical Practice Guidelines We Can Trust Institute of Medicine, Board on Health Care Services, Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, 2011-06-16 Advances in medical, biomedical and health services research have reduced the level of uncertainty in clinical practice. Clinical practice guidelines (CPGs) complement this progress by establishing standards of care backed by strong scientific evidence. CPGs are statements that include recommendations intended to optimize patient care. These statements are informed by a systematic review of evidence and an assessment of the benefits and costs of alternative care options. Clinical Practice Guidelines We Can Trust examines the current state of clinical practice guidelines and how they can be improved to enhance healthcare quality and patient outcomes. Clinical practice guidelines now are ubiquitous in our healthcare system. The Guidelines International Network (GIN) database currently lists more than 3,700 guidelines from 39 countries. Developing guidelines presents a number of challenges including lack of transparent methodological practices, difficulty reconciling conflicting guidelines, and conflicts of interest. Clinical Practice Guidelines We Can Trust explores questions surrounding the quality of CPG development processes and the establishment of standards. It proposes eight standards for developing trustworthy clinical practice guidelines emphasizing transparency; management of conflict of interest ; systematic review-guideline development intersection; establishing evidence foundations for and rating strength of guideline recommendations; articulation of recommendations; external review; and updating. Clinical Practice Guidelines We Can Trust shows how clinical practice guidelines can enhance clinician and patient decision-making by translating complex scientific research findings into recommendations for clinical practice that are relevant to the individual patient encounter, instead of implementing a one size fits all approach to patient care. This book contains information directly related to the work of the Agency for Healthcare Research and Quality (AHRQ), as well as various Congressional staff and policymakers. It is a vital resource for medical specialty societies, disease advocacy groups, health professionals, private and international organizations that develop or use clinical practice guidelines, consumers, clinicians, and payers. |
| aha guidelines htn: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure U. S. Department of Health and Human Services, National Insitutes of Health, National Heart Lung Institute, And, 2013-06-21 The purpose of the “Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7)” is to provide an evidence-based approach to the prevention and management of hypertension. The key messages of this report are: in those older than age 50, systolic blood pressure (SBP) of greater than 140 mmHg is a more important cardiovascular disease (CVD) risk factor than diastolic BP (DBP); beginning at 115/75 mmHg, CVD risk doubles for each increment of 20/10 mmHg; those who are normotensive at 55 years of age will have a 90 percent lifetime risk of developing hypertension; prehypertensive individuals (SBP 120–139 mmHg or DBP 80–89 mmHg) require health promoting lifestyle modifications to prevent the progressive rise in blood pressure and CVD; for uncomplicated hypertension, thiazide diuretic should be used in drug treatment for most, either alone or combined with drugs from other classes; this report delineates specific high-risk conditions, which are compelling indications for the use of other antihypertensive drug classes (angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, beta blockers, calcium channel blockers); two or more antihypertensive medications will be required to achieve goal BP (less than 140/90 mmHg, or less than 130/80 mmHg for patients with diabetes and chronic kidney disease); for patients whose BP is greater than 20 mmHg above the SBP goal or 10 mmHg above the DBP goal, initiation of therapy using two agents, one of which usually will be a thiazide diuretic, should be considered; regardless of therapy or care, hypertension will only be controlled if patients are motivated to stay on their treatment plan. Positive experiences, trust in the clinician, and empathy improve patient motivation and satisfaction. This report serves as a guide, and the committee continues to recognize that the responsible physician's judgment remains paramount. |
| aha guidelines htn: Clinical Guide to Cardiology Christian Fielder Camm, A. John Camm, 2016-01-06 Clinical Guide to Cardiology is a quick-reference resource, packed full of bullet points, diagrams, tables and algorithms for the key concepts and facts for important presentations and conditions within cardiology. It provides practical, evidence-based information on interventions, investigations, and the management of clinical cardiology. Key features include: A clear evidence-base providing key guidelines and clinical trials in each chapter Coverage of examination techniques, common conditions, imaging modalities (including ECGs, chest X-rays, MRI and CT), interventional therapies, and pharmacology A companion website at www.wiley.com/go/camm/cardiology featuring audio clips, developed for differing levels of knowledge, that explain key concepts or an area in greater detail, as well as numerous additional clinical case studies, audio scripts, and self-assessment material |
| aha guidelines htn: Mayo Clinic 5 Steps to Controlling High Blood Pressure Sheldon G. Sheps, 2015-12-04 How to play a vital role in your own health and longevity: A handbook from“one of the most reliable, respected health resources that Americans have” (Publishers Weekly). This easy-to-use guide will help you understand the many issues related to high blood pressure and assist you in preventing it, managing it, and making essential treatment decisions. · Learn which single factor you can do the most about when it comes to influencing your blood pressure. This one step may be all it takes to lower your blood pressure and keep it under control. · How losing as little as 10 pounds may reduce your blood pressure to a healthier level—includes practical help for maintaining a healthier weight. · Discover a great alternative that may lower your blood pressure just about as much as medications—without the expense of prescriptions. · Why your blood pressure goes down if you make your heart stronger—and dozens of tips to realize this goal. · How to manage your sodium intake. · Information about medications for when changes in lifestyle aren't enough and more |
| aha guidelines htn: ABC of Hypertension D. Gareth Beevers, Gregory Y. H. Lip, Eoin T. O'Brien, 2010-07-15 Hypertension is a condition which affects millions of peopleworldwide and its treatment greatly reduces the risk of strokes andheart attacks. This fully revised and updated edition of the ABCof Hypertension is an established guide providing all thenon-specialist needs to know about the measurement of bloodpressure and the investigation and management of hypertensivepatients. This new edition provides comprehensively updated andrevised information on how and whom to treat. The ABC of Hypertension will prove invaluable to generalpractitioners who may be screening large numbers of patients forhypertension, as well as nurse practitioners, midwives and otherhealthcare professionals. |
| aha guidelines htn: Hypertension: New Frontiers HK Chopra, 2021-03-31 Hypertension is another name for high blood pressure. It can lead to severe complications and increases the risk of heart disease, stroke, and death. Blood pressure is the force exerted by the blood against the walls of the blood vessels. Comprising more than 1000 pages, this book is a complete guide to the diagnosis and management of hypertension. Divided into 19 sections, the text begins with an introduction to hypertension, its causes, risk factors, and how it presents in different sectors of the population. The next chapters discuss diagnostic methods and echocardiography. The following sections cover hypertension associated with other disorders including heart failure, stroke, renovascular diseases, metabolic syndrome, and many more. Numerous clinical management strategies are discussed in depth, as well as cardio-oncology, nutrition, and ECMO (Extracorporeal Membrane Oxygenation – a procedure that uses a machine to take over the work of the lungs and sometimes, the heart). A complete section is dedicated to paediatric cardiology and hypertension. With an internationally recognised editor and author team, the comprehensive text is highly illustrated with clinical photographs, diagrams and tables. The book also includes full online access. Key points Comprehensive guide to diagnosis and management of hypertension comprising over 1000 pages Internationally recognised editor and author team Highly illustrated with clinical photographs, diagrams and tables Includes full online access to the book |
| aha guidelines htn: Carbon Dioxide Angiography Kyung Cho, Irvin F. Hawkins, 2007-07-17 With an abundance of illustrations and tables to highlight critical information, this source provides a practical approach to the use of CO2 as a contrast agent for diagnostic angiography, vascular intervention, and other interventional procedures in both adults and pediatrics. Clearly laying-out key points in the science, technique, and clinical a |
| aha guidelines htn: Trends in the Use of Complementary Health Approaches Among Adults Tainya C. Clarke, 2015 |
| aha guidelines htn: Five-year Findings of the Hypertension Detection and Follow-up Program National Heart, Lung, and Blood Institute. Hypertension Detection and Follow-up Program Cooperative Group, 1979 |
| aha guidelines htn: Coronary Primary Prevention Trial , 1984 |
| aha guidelines htn: Clinical Guidelines for the Management of Hypertension Oussama M. N.. Khatib, World Health Organization. Regional Office for the Eastern Mediterranean, Mohamed Sayed El-Guindy, 2005 Good management is central to any strategy formulated to control hypertension at the community level. These guidelines are aimed at standardizing the management and care of hypertension, including control of blood pressure and complications in people with established hypertension and identification of individuals with high blood pressure who are at increased risk of complications; and at promoting integration of prevention of hypertension into primary health care settings, including lifestyle measures for prevention and management and cost-effectiveness. The guidelines are intended to benefit physicians at primary, secondary and tertiary level, general practitioners, internists and family medicine specialists, clinical dieticians and nurses as well as health and policy-makers. They provide the necessary information for decision-making by health care providers or patients themselves about disease management in the most commonly encountered situations. |
| aha guidelines htn: Pericardial Disease J. Soler-Soler, G. Permanyer, J. Sagristà-Sauleda, 2012-12-06 In November 1986, I was invited to attend a symposium held in Barcelona on Diseases of the Pericardium. The course was directed by Dr. J. Soler-Soler, director of Cardiology at Hospital General Vall d'Hebron in Barcelona. During my brief but delightful visit to this institution, my appreciation of the depth and breadth of study into pericardial diseases, carried out by Dr. Soler and his group, grew into the conviction that these clinical investigators have accumulated a wealth of information concerning pericardial diseases, and that investigators and clinicians practicing in English speaking countries would greatly profit from ready access to the results of the clinical investiga tions into pericardial disease carried out in Barcelona. The proceedings of the Barcelona conference were published in a beauti fully executed volume in the Spanish language edited by Dr. Soler and pro duced by Ediciones Doyma. Because I believe that this work should be brought to the attention of the English speaking scientific and clinical com munities, I encouraged Dr. Soler to have the book translated into English. I knew that this task could be accomplished and that the book would be trans lated into good English without change of its content. My confidence was based upon a translation of my own book, The Pericardium, into Spanish undertaken by Dr. Permanyer, who is a contributor and co-editor of the pre sent volume. |
| aha guidelines htn: Hypertension in the Elderly L. Michael Prisant, 2007-11-05 A comprehensive review of all aspects of hypertension in the elderly using the most current clinical data. Topics range from basic concepts, epidemiology and trials, and evaluation and management, to pharmacologic treatment, special populations, and adherence, all presented with an emphasis on the optimal management of patients. The authors examine in detail the mechanisms of hypertension in the elderly, the lifestyle trials and outcomes trials that were conducted in older persons, as well as the problems of clinical evaluation, secondary hypertension, adherence, and target organ damage. Extensive discussions of pharmacologic therapy detail the role of all the major drug classes. |
| aha guidelines htn: Hypertension Among Adults in the United States Tatiana Nwankwo, Sung Sug Yoon, Vicki L. Burt, 2013 |
| aha guidelines htn: Disease Control Priorities, Third Edition (Volume 5) Dorairaj Prabhakaran, Shuchi Anand, Thomas A. Gaziano, Jean-Claude Mbanya, Yangfeng Wu, Rachel Nugent, 2017-11-17 Cardiovascular, respiratory, and related conditions cause more than 40 percent of all deaths globally, and their substantialburden is rising, particularly in low- and middle-income countries (LMICs). Their burden extends well beyond health effects to include significanteconomic and societal consequences. Most of these conditions are related, share risk factors, and have common control measures at theclinical, population, and policy levels. Lives can be extended and improved when these diseases are prevented, detected, and managed. This volume summarizes current knowledge and presents evidence-based interventions that are effective, cost-effective, and scalable in LMICs. |
| aha guidelines htn: Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics William B. White, 2000-11-01 Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics provides information that will be especially useful to all who care for hyperten sive patients. The various chapters provide a full account of the mounting sci entific evidence that blood pressure recordings need to be obtained for proper diagnosis, prognosis, and therapy for these patients. The contributors are each directly involved in clinical studies ofhome and ambulatory blood pressure moni toring, as well as of the relationship of circadian variations in heart rate and blood pressure to cardiovascular events. As a longtime observer of the multiple facets of clinical hypertension, I have been greatly impressed with the rapid advances in this area over the last two decades. Out-of-office blood pressure monitoring has grown from a curi osity to a necessity. In order to improve the currently inadequate control of hypertension throughout the world, such monitoring should become routine in the diagnosis and treatment of every patient. The evidence for the role of out-of-office monitoring that is so well described in Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics should serve as a stimulus for the more widespread adoption of the procedure. Once this is understood, the constraints on the broader clinical use of ambulatory monitoring that now exist in the United States will be lifted as the value of such information becomes more generally recognized. In the meantime, self-recorded home measurements should be more widely utilized. |
| aha guidelines htn: Adherence to Long-term Therapies Eduardo Sabaté, World Health Organization, 2003 This report is based on an exhaustive review of the published literature on the definitions, measurements, epidemiology, economics and interventions applied to nine chronic conditions and risk factors. |
| aha guidelines htn: Management of Hypertension Vasilios Papademetriou, Emmanuel A. Andreadis, Charalampia Geladari, 2018-11-19 This book is a valuable tool to assist both cardiovascular physicians and scientists learning the intricacies of hypertension research and its milestone studies. All major hypertension trials have been reviewed in this book in chronological order with extensive discussion of the study population, study design, and outcomes and with a special focus on what knowledge they offered, their strengths and weaknesses, statistical errors, impact on international guidelines and unmet needs. Importantly, the book also offers physicians and young scientists with basic knowledge regarding medical biostatistics. It is of critical importance for a scientist involved in the field to understand deeply the process of analyzing medical data. Moreover, the accurate interpretation of the results is central for applying evidence-based medicine in everyday clinical practice. Management of Hypertension: Current Practice and the Application of Landmark Trials is a critical tool to assist in the education of physicians and researchers in the field, providing a separate section on pioneer researchers in hypertension and urging readers to become bright exemplars for scientists wishing to pursue a career in academic medicine and hypertension research. |
| aha guidelines htn: Hypertension - E-Book George L. Bakris, Matthew Sorrentino, Luke J. Laffin, 2023-08-29 **Selected for Doody's Core Titles® 2024 in Cardiology**Part of the renowned Braunwald family of references, Hypertension: A Companion to Braunwald's Heart Disease provides today's clinicians with clear, authoritative guidance on every aspect of managing and treating patients who suffer from hypertensive disorders. An invaluable resource for cardiologists, endocrinologists, and nephrologists, this one-stop reference covers all the latest developments from basic science to clinical trials and guidelines related to the treatment of common to complex hypertension. Now fully updated from cover to cover, the 4th Edition offers unparalleled coverage of hypertension in an accessible and user-friendly manner. - Thoroughly covers new treatment guidelines related to recent research and the latest physiologic understanding for a wide range of patients with hypertension and related co-morbidities - Includes new chapters on Hypertension in Women, Mineralocorticoid Receptor Antagonists, Exercise and Hypertension, and Telemedicine/Digital Health - Contains new or expanded content on epidemiology, pathophysiology, immunology, clinical findings, laboratory testing, invasive and non-invasive testing, risk stratification, clinical decision-making, prognosis, and management - Provides new chapter summaries and a new focus on clinical and actionable content using a streamlined, narrative format - Covers behavior management and prevention as an integral part of hypertensive and pre-hypertensive treatment plans - Highlights combination drug therapies and management of chronic complications of hypertension - Offers expert guidance from worldwide experts in cardiology, endocrinology, and nephrology, and integrates the most recent guidelines from leading organizations around the world |
| aha guidelines htn: Guidelines for Cardiac Rehabilitation Programs American Association of Cardiovascular & Pulmonary Rehabilitation, 2021 Guidelines for Cardiac Rehabilitation Programs, Sixth Edition, offers procedures for providing patients with low-cost, high-quality programming that moves them toward a lifelong commitment to disease management. |
| aha guidelines htn: Adult-Gerontology Practice Guidelines Jill C. Cash, MSN, APN, FNP-BC, 2023-02-13 Praise for the First Edition: Because of the way it is organized, this book meets the needs of both novice and experienced advance practice nurses. Each chapter defines the problem, how often it occurs, and what leads to the problem. To aid in assessment, the book includes the physical examination landmarks as well as diagnostic tests that might be needed. A plan of care is offered with several different alternatives for treatment and then notes what type of follow-up is needed. This would be a great resource for anyone working in the field of geriatrics...Score: 92 - 4 Stars! --Doody's Reviews This hands-on text and clinical reference--used by thousands of NP students and practitioners alike--delivers national practice guidelines and professional standards of care to help clinicians deliver optimal primary care to adult and older adult patients. The new third edition, featuring the expert input of two renowned Adult-Gerontology practitioners, updates all chapters, teaching guides, and illustrative charts and provides new charts to enhance readability. Fresh content includes information on Sjogren's syndrome; reactive arthritis; elder abuse; LGBTQ health; concussion assessment; joint pain, bursitis, and fractures; peripheral neuropathy; and perimenopause/menopause. The third edition also includes the updated Beers Criteria and covers COVID-19 treatment and vaccines. Ideal for quick reference and as a study guide, the text presents the most up-to-date guidelines in a consistent, easy-to-read, bulleted format. Conveniently organized by body system, it features detailed content on the physical examination and diagnostic testing, information on health promotion, guidelines of care, dietary information, common procedures, national patient resources, and popular Client Teaching Guides--available in print and digital format--that serve as both patient handouts and concise study tools. Clinical points throughout the text highlight critical practice considerations. The book, with its great breadth and depth of information, will be a welcome companion for NP students as they transition to professional practice and beyond. New to the Third Edition: Completely updated content including patient teaching guides and charts New charts added to enhance comprehension Coverage of Sjogren's syndrome; reactive arthritis; elder abuse; LGBTQ health; concussion assessment; joint pain, bursitis, and fractures; peripheral neuropathy, and perimenopause/menopause Latest guidelines on COVID-19 treatment and vaccines Updated Beers Criteria Current CDC recommendations on vaccines and cancer screening Key Features: Offers consistent guidelines for over 275 disorders Presents practice guidelines organized by body system Lists disorders alphabetically for easy access Highlights key considerations for practice Delivers individual care considerations for adult, geriatric, and pregnant patients Provides Client Teaching Guides serving as both take-home teaching supplements for patients and a concise study tool for students |
| aha guidelines htn: Diagnosis and Treatment of Pulmonary Hypertension Yoshihiro Fukumoto, 2018-12-12 This book focuses on pulmonary arterial hypertension (PAH, Group 1) and chronic thromboembolic pulmonary hypertension (CTEPH, Group 4) among the various groups of pulmonary hypertension (PH) whose classification was updated into five major categories at the 5th World Symposium held in Nice, France, in 2013. Readers will find recent progress, methods, and up-to-date information on PH mechanisms, diagnostic images, and treatment in the management of PH.This volume, with contributions by leading researchers worldwide in the field , consists of five parts, starting with the fundamentals of PH, then pathophysiology and genetics, treatment, and right ventricular function. |
| aha guidelines htn: Hypertension George Bakris, Ragavendra R. Baliga, 2012-07-30 Over 75 million American adults suffer from hypertension, the leading risk factor for stroke and cardiovascular disease. Individuals who are normotensive at age 55 have a 90% lifetime risk for developing high blood pressure. Despite increased awareness in the past decades, about a third of adults with hypertension are not aware of their condition. With the growing prevalence of obesity, hypertension will continue to affect more individuals and, along with diabetes, will become the primary cause of cardiovascular morbidity and mortality. As part of the Oxford American Cardiology Library, this practical handbook is a concise yet comprehensive guide to overcoming the challenges of hypertension treatment. Written by leading experts in the field, this volume collects clinically oriented, up-to-date knowledge on accurate diagnosis, antihypertensive therapies, management of comorbidities, and hypertension in special populations. Featuring evidence-based discussions of key clinical concepts and therapy options, with numerous figures, tables, and illustrations, this pocket-sized handbook will serve as an invaluable guide to healthcare professionals. |
| aha guidelines htn: Ventricular Arrhythmias John M. Miller, 2008 Ventricular arrhythmias cause most cases of sudden cardiac death, which is the leading cause of death in the US. This issue reviews the causes of arrhythmias and the promising new drugs and devices to treat arrhythmias. |
| aha guidelines htn: Progress in Brain Research J. P. Schadé, John Stirling Meyer, 1963 |
| aha guidelines htn: Hypertension Primer Joseph L. Izzo, Domenic A. Sica, Henry Richard Black, 2008 Now in its thoroughly updated Fourth Edition, the Hypertension Primer is a comprehensive, readable source of state-of-the-art scientific and clinical information on hypertension. The book contains 171 short chapters by distinguished experts that cover every aspect of hypertension and its pathogenesis, epidemiology, impact, and management. Highlights of this edition include updated JNC 7 findings regarding special population therapy and clinical management. Chapters are grouped into three well-organized sections—basic science, population science, and clinical management—and each chapter is cross-referenced to other relevant chapters. Each chapter is easily digestible and begins with a bulleted list of key points. |
| aha guidelines htn: Collins-Bride & Saxe's Clinical Guidelines for Advanced Practice Nursing Yoonmee Joo, Jim V. Gatewood, Mary Anne Israel, Kelly Wong McGrath, 2024 Collins-Bride & Saxe's Clinical Guidelines for Advanced Practice Nursing, Fourth Edition is an accessible and practical reference designed to help nurses and students with daily clinical decision making. Written in collaboration with certified nurse midwives, clinical nurse specialists, nurse practitioners, nutritionists, pharmacists, and physicians, it fosters a team approach to health care. Divided into four areas-Pediatrics, Gynecology, Obstetrics, and, Adult General Medicine-and following a lifespan approach, it utilizes the S-O-A-P (Subjective-Objective-Assessment-Plan) format. Additionally, the authors explore complex chronic disease management, health promotion across the lifespan, and professional and legal issues such as reimbursement, billing, and the legal scope of practice. The Fourth Edition has a keen focus on gerontology to accommodate the AGNP specialty and to better assist the student or clinician in caring for the aging population. The authors follow the across the life span approach and focus on common complete disorders. Certain chapters have been revised and new chapters have been added which include:Health Maintenance for Older Adults; Frailty; Common Gerontology Syndromes; Cancer Survivorship; Lipid Disorders; Acne (pediatrics section) |
| aha guidelines htn: Manual of Hypertension BA Muruganathan, 2020-11-30 Hypertension is another name for high blood pressure. It can lead to severe complications and increases the risk of heart disease, stroke, and death. Blood pressure is the force exerted by the blood against the walls of the blood vessels. The new edition of this manual provides cardiologists with the latest advances in the diagnosis and management of hypertension. Divided into 14 sections, the book begins with an overview of the history and epidemiology of the condition, risk factors, pathophysiological aspects, and molecular basis. The next chapters discuss the accuracy of blood pressure measurements, target organ damage, and secondary hypertension. The book concludes with chapters on therapeutic aspects, genetics, and the latest treatment guidelines and meta-analysis. The second edition has been fully revised and includes new topics in line with recent advances in the field. Clinical images and figures further enhance the comprehensive text. Key points Comprehensive guide to diagnosis and management of hypertension Fully revised, second edition featuring new topics in line with recent advances and guidelines Highly illustrated with clinical images and figures Previous edition (9789352500307) published in 2016 |
Clinical Practice Guidelines - AHA/ASA Journals
The 2020 ISH Global Hypertension Practice Guidelines were developed by the ISH Hypertension Guidelines Committee based on evidence criteria, (1) to be used globally; (2) to be fit for …
High Blood Pressure | American Heart Association
What is high blood pressure or hypertension? The American Heart Association provides information on high blood pressure, low blood pressure, and how to monitor, treat and prevent …
Guideline-Driven Management of Hypertension: An …
Two well-performed simulation studies demonstrate a highly positive population impact of following the 2017 ACC/AHA hypertension guideline recommendations for lowering BP in …
The Management of Elevated Blood Pressure in the
Markedly elevated BP is defined by the 2017 Hypertension Clinical Practice Guidelines as systolic BP (SBP) >180 mm Hg or diastolic BP (DBP) >120 mm Hg in scenarios without new or …
Guideline-Driven Management of Hypertension: - AHA/ASA …
Apr 1, 2021 · Several important findings bearing on the prevention, detection, and management of hypertension have been reported since publication of the 2017 American College of …
The Management of Elevated Blood Pressure in the ... - AHA/ASA …
May 28, 2024 · Markedly elevated BP is defined by the 2017 Hypertension Clinical Practice Guidelines as systolic BP (SBP) >180 mm Hg or diastolic BP (DBP) >120 mm Hg in scenarios …
2020 International Society of Hypertension Global Hypertension …
May 6, 2020 · To align with its mission to reduce the global burden of raised blood pressure (BP), the International Society of Hypertension (ISH) has developed worldwide practice guidelines …
2017 Guideline for High Blood Pressure in Adults
May 7, 2018 · Normal BP is defined as <120/<80 mm Hg; elevated BP 120-129/<80 mm Hg; hypertension stage 1 is 130-139 or 80-89 mm Hg, and hypertension stage 2 is ≥140 or ≥90 …
2024 AHA Scientific Statement on Management of Elevated Blood …
Aug 13, 2024 · Elevated BP in the inpatient setting can be classified as asymptomatic elevated BP versus HTN emergency (elevated BP with signs of new or worsening target-organ …
Guideline-Driven Management of Hypertension: An Evidence …
In November 2017, the American College of Cardiology (ACC)/American Heart Association (AHA) in partnership with nine other professional societies published a BP guideline that redefined …
Clinical Practice Guidelines - AHA/ASA Journals
The 2020 ISH Global Hypertension Practice Guidelines were developed by the ISH Hypertension Guidelines Committee based on evidence …
High Blood Pressure | American Heart Association
What is high blood pressure or hypertension? The American Heart Association provides information on high blood pressure, low blood …
Guideline-Driven Management of Hypertens…
Two well-performed simulation studies demonstrate a highly positive population impact of following the 2017 ACC/AHA hypertension guideline …
The Management of Elevated Blood Pressure in the ... - A…
Markedly elevated BP is defined by the 2017 Hypertension Clinical Practice Guidelines as systolic BP (SBP) >180 mm Hg or diastolic BP (DBP) >120 …
Guideline-Driven Management of Hypertensi…
Apr 1, 2021 · Several important findings bearing on the prevention, detection, and management of hypertension have been reported since publication of …
